Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis F Parada

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Neuron|November 7, 2024
Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrenceXuanhua P Xie, Mungunsarnai Ganbold, Jing Li, et al.
Cancer Research|November 29, 2013
Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumorsVincent Chau, S Kyun Lim, Wei Mo, et al.
Blood|November 9, 2006
Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant miceAndrew Kim, Kelly Morgan, Diane E Hasz, et al.
Plos One|August 24, 2012
Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growthTae Hyong Kim, Jieun Song, Sheila R Alcantara Llaguno, et al.
The Journal of Comparative Neurology|November 23, 2013
PTEN knockdown alters dendritic spine/protrusion morphology, not densityMichael E Haws, Thomas C Jaramillo, Felipe Espinosa, et al.
Nature|March 8, 2019
Gboxin is an oxidative phosphorylation inhibitor that targets glioblastomaYufeng Shi, S Kyun Lim, Qiren Liang, et al.
Cell|February 26, 2013
CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumorsWei Mo, Jian Chen, Amish Patel, et al.
Biological Psychiatry|November 8, 2008
Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine rewardDanielle L Graham, Vaishnav Krishnan, Erin B Larson, et al.
Molecular and Cellular Biology|May 6, 2009
Ral overactivation in malignant peripheral nerve sheath tumorsVidya Bodempudi, Farnaz Yamoutpoor, Weihong Pan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2009
PTEN dosage is essential for neurofibroma development and malignant transformationCaroline Gregorian, Jonathan Nakashima, Sarah M Dry, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Neuron|November 7, 2024
Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrenceXuanhua P Xie, Mungunsarnai Ganbold, Jing Li, et al.
Cancer Research|November 29, 2013
Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumorsVincent Chau, S Kyun Lim, Wei Mo, et al.
Blood|November 9, 2006
Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant miceAndrew Kim, Kelly Morgan, Diane E Hasz, et al.
Plos One|August 24, 2012
Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growthTae Hyong Kim, Jieun Song, Sheila R Alcantara Llaguno, et al.
The Journal of Comparative Neurology|November 23, 2013
PTEN knockdown alters dendritic spine/protrusion morphology, not densityMichael E Haws, Thomas C Jaramillo, Felipe Espinosa, et al.
Nature|March 8, 2019
Gboxin is an oxidative phosphorylation inhibitor that targets glioblastomaYufeng Shi, S Kyun Lim, Qiren Liang, et al.
Cell|February 26, 2013
CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumorsWei Mo, Jian Chen, Amish Patel, et al.
Biological Psychiatry|November 8, 2008
Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine rewardDanielle L Graham, Vaishnav Krishnan, Erin B Larson, et al.
Molecular and Cellular Biology|May 6, 2009
Ral overactivation in malignant peripheral nerve sheath tumorsVidya Bodempudi, Farnaz Yamoutpoor, Weihong Pan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2009
PTEN dosage is essential for neurofibroma development and malignant transformationCaroline Gregorian, Jonathan Nakashima, Sarah M Dry, et al.
Pageof 14